Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21

Eun-Kee Song

Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21

Eun-Kee Song

Department of Medicine

Research output: Contribution to journal › Journal article › peer-review

Original language	Korean
Journal	Oncologist
State	Published - 2015.12.1

Cite this

@article{633cbf72309f474695e586cac1995364,

title = "Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21",

author = "Eun-Kee Song",

year = "2015",

month = dec,

day = "1",

language = "Korean",

journal = "Oncologist",

issn = "1083-7159",

}